A 24-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Peripheral Neuropathy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04005287 |
|
Recruitment Status :
Completed
First Posted : July 2, 2019
Last Update Posted : December 16, 2022
|
Sponsor:
WinSanTor, Inc
Information provided by (Responsible Party):
WinSanTor, Inc
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | December 15, 2021 |
| Actual Study Completion Date : | December 15, 2021 |
| Certification/Extension First Submitted : | December 14, 2022 |